• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Zollinger-Ellison phenotype in the absence of hypergastrinemia and islet-cell tumor.

作者信息

Desai Anish A, McGuigan James E, Draganov Peter

机构信息

University of Florida, Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Gainesville, FL 32610, USA.

出版信息

Int J Gastrointest Cancer. 2005;35(2):157-61. doi: 10.1385/IJGC:35:2:157.

DOI:10.1385/IJGC:35:2:157
PMID:15879632
Abstract

Patients with the Zollinger-Ellison syndrome are characterized by islet-cell tumors, striking gastric acid hypersecretion, and peptic ulcer disease. They often experience severe abdominal pain, diarrhea, and gastrointestinal bleeding with potentially life-threatening consequences. It is a rare syndrome caused by non-beta cell islet-cell tumors (gastrinomas) located in or in proximity to the pancreas. These tumors freely secrete gastrin, a peptide hormone that serves as a powerful stimulant of gastric acid secretion. Exuberant secretion of gastrin from the gastrinomas produces severe gastric acid hypersecretion that often leads to impressive peptic ulcer disease and the constellation of symptoms listed above. We describe a patient presenting with clinical manifestations characteristic of the ZES with strikingly elevated gastric acid secretion,multiple ulcers in the first and second portions of the duodenum and diarrhea, but in absence of islet-cell tumor and/or hypergastrinemia.

摘要

相似文献

1
Zollinger-Ellison phenotype in the absence of hypergastrinemia and islet-cell tumor.
Int J Gastrointest Cancer. 2005;35(2):157-61. doi: 10.1385/IJGC:35:2:157.
2
[Zollinger-Ellison syndrome].[佐林格-埃利森综合征]
Wien Klin Wochenschr. 1984 Feb 17;96(4):138-44.
3
Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.质子泵抑制剂时代胃泌素瘤的诊断与治疗
Wien Klin Wochenschr. 2007;119(19-20):573-8. doi: 10.1007/s00508-007-0884-2.
4
Islet cell tumors and the ulcerogenic syndrome.胰岛细胞瘤与致溃疡综合征。
Monogr Pathol. 1980;21:177-84.
5
A new cause of Zollinger-Ellison syndrome: non-small cell lung cancer.
Gastroenterology. 2001 Apr;120(5):1271-8. doi: 10.1053/gast.2001.23242.
6
Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.口服溴隐亭对两名佐林格-埃利森综合征患者高胃泌素血症无影响。
J Endocrinol Invest. 1978 Oct;1(4):351-3. doi: 10.1007/BF03350981.
7
Zollinger-Ellison syndrome. Diagnosis and therapy.佐林格-埃利森综合征。诊断与治疗。
Minerva Med. 2005 Jun;96(3):187-206.
8
Resection of gastrinoma in the Zollinger-Ellison syndrome.卓-艾综合征中胃泌素瘤的切除术
Gastroenterology. 1982 May;82(5 Pt 1):953-6.
9
Mechanism of the gastric hypersecretion in the Zollinger-Ellison syndrome: successful extraction of gastrin-like activity from metastases and primary pancreatico-duodenal islet cell carcinoma.佐林格-埃利森综合征胃分泌过多的机制:从转移灶和原发性胰十二指肠胰岛细胞瘤中成功提取胃泌素样活性。
Ann Surg. 1962 Feb;155(2):167-74. doi: 10.1097/00000658-196200000-00001.
10
Clinical recovery owing to target parietal cell failure in a patient with Zollinger-Ellison syndrome.一名卓-艾综合征患者因目标壁细胞衰竭而实现临床康复。
Gastroenterology. 1977 Dec;73(6):1413-7.

引用本文的文献

1
Typical Zollinger-Ellison syndrome-atypical location of gastrinoma and absence of hypergastrinemia: A case report and review of literature.典型的佐林格-埃利森综合征——胃泌素瘤的非典型位置及无高胃泌素血症:一例病例报告并文献复习
World J Clin Cases. 2023 Sep 16;11(26):6223-6230. doi: 10.12998/wjcc.v11.i26.6223.
2
Gastric acid hypersecretory states: recent insights and advances.胃酸分泌过多状态:最新见解与进展
Curr Gastroenterol Rep. 2009 Dec;11(6):433-41. doi: 10.1007/s11894-009-0067-6.

本文引用的文献

1
Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.空肠原发性消化性溃疡与胰腺胰岛细胞瘤相关。
Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8.
2
Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.维持性口服泮托拉唑治疗对卓-艾综合征和特发性胃酸分泌过多患者有效。
Am J Gastroenterol. 2003 Feb;98(2):301-7. doi: 10.1111/j.1572-0241.2003.07262.x.
3
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
散发性胃泌素瘤和胰岛素瘤中MEN1肿瘤抑制基因的体细胞突变。
Cancer Res. 1997 Nov 1;57(21):4682-6.
4
Mechanism of gastric acid hypersecretion in patients with islet cell tumor without hypergastrinemia: studies in rats.无高胃泌素血症的胰岛细胞瘤患者胃酸分泌过多的机制:大鼠研究
Gastroenterology. 1997 Oct;113(4):1129-35. doi: 10.1053/gast.1997.v113.pm9322507.
5
Localization of gastrinomas.胃泌素瘤的定位
Int J Pancreatol. 1996 Apr;19(2):79-91. doi: 10.1007/BF02805221.
6
Neuroendocrine tumors of the pancreas and duodenum.胰腺和十二指肠神经内分泌肿瘤
Curr Probl Surg. 1994 Feb;31(2):77-156. doi: 10.1016/0011-3840(94)90079-5.
7
Secretin injection test in the diagnosis of gastrinoma.用于诊断胃泌素瘤的促胰液素注射试验。
Gastroenterology. 1980 Dec;79(6):1324-31.
8
Non-gastrin secretogogue in ulcerogenic tumors of the pancreas.胰腺致溃疡肿瘤中的非胃泌素促分泌素
Ann Intern Med. 1984 Jul;101(1):7-13. doi: 10.7326/0003-4819-101-1-7.
9
Changing concepts in the presentation, diagnosis and management of the Zollinger-Ellison syndrome.佐林格-埃利森综合征在临床表现、诊断及治疗方面不断变化的概念
Q J Med. 1983 Spring;52(206):256-67.
10
Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety.对患有佐林格-埃利森型胰腺肿瘤患者血清中胃泌素水平升高进行免疫化学测定。
N Engl J Med. 1968 Jun 13;278(24):1308-13. doi: 10.1056/NEJM196806132782402.